Alterations in the p53 pathway and prognosis in advanced ovarian cancer: A multi-factorial analysis of the EORTC Gynaecological Cancer group (study 55865)
Open Access
- 1 October 2006
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (15), 2539-2548
- https://doi.org/10.1016/j.ejca.2006.06.015
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Critical evaluation of p53 as a prognostic marker in ovarian cancerExpert Reviews in Molecular Medicine, 2004
- The role of interval debulking surgery in ovarian cancer.Current Oncology Reports, 2003
- Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancerAnnals of Oncology, 2003
- Prognostic factors in ovarian cancer: current evidence and future prospectsEuropean Journal of Cancer Supplements, 2003
- Immunohistochemically Detected p53 Mutations in Epithelial Tumors and Results of Treatment with Chemotherapy and RadiotherapyStrahlentherapie und Onkologie, 2002
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinomaInternational Journal of Gynecologic Cancer, 2001
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerNew England Journal of Medicine, 1995
- Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic SignificanceGynecologic Oncology, 1995
- Testing the validity of a prognostic classification in patients with surgically optimal ovarian carcinoma: a 15-year reviewInternational Journal of Gynecologic Cancer, 1993